Role of inhaled antibacterials in hospital-acquired and ventilator-associated pneumonia

References

• Spellburg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 38, 1279–1286 (2004).
   PubMedGoogle Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 23,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39, 309–317 (2004).
   PubMed Web of Science ®Google Scholar
• National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance System Report, data summary from January 1992 through to June 2003, issued August 2003. Am. J. Infect. Control 31, 481–498 (2003).
   PubMed Web of Science ®Google Scholar
• Ramsey BW, Dorkin HL, Eisenberg JD et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N. Engl. J. Med. 45, 2502–2509 (1993).
   Google Scholar
• Tobramycin Solution for Inhalation (TOBI®). PathoGenesis Corporation, Seattle, WA, USA (1998).
   Google Scholar
• Ryan G, Mukhopadhyay S, Singh M. Nebulized antipseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst. Rev. 3, CD001021 (2003).
   Google Scholar
• Touw DJ, Jacobs FAH, Brimicombe RE et al. Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis. Antimicrob. Agents Chemother. 41, 184–187 (1997).
   PubMed Web of Science ®Google Scholar
• Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am. Rev. Respir. Dis. 132, 761–765 (1985).
   PubMed Web of Science ®Google Scholar
• Smaldone GC. Aerosolized antibiotics in mechanically ventilated patients. Respir. Care. 49, 635–639 (2004).
   PubMedGoogle Scholar
• Goldstein I, Wallet F, Nicolas-Robin A et al. Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am. J. Respir. Crit. Care Med. 166, 1375–1381 (2002).
   PubMed Web of Science ®Google Scholar
• Elman M, Goldstein I, Charles-Hugo MD et al. Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 97, 199–206 (2002).
   PubMedGoogle Scholar
• Gilbert DN. Aminoglycosides. In: Principles and Practice of Infectious Diseases. Sixth Edition. Mandell DL, Bennett JC, Dolin R (Eds), Elsivier Inc., PA, USA, 328–356 (2005).
   Google Scholar
• Smaldone GC, Palmer LB. Aerosolized antibiotics: current and future. Respir. Care 45, 667–675 (2000).
   PubMedGoogle Scholar
• Hamill RJ, Houston ED, Georghiu PR et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann. Intern. Med. 122, 762–766 (1995).
   PubMed Web of Science ®Google Scholar
• Craven DE, Lichtenberg DA, Goularte TA, Make BJ, McCabe WR. Contaminated medication nebulizers in mechanical ventilator circuits: source of bacterial aerosols. Am. J. Med. 77, 834–838 (1984).
   PubMed Web of Science ®Google Scholar
• Beaty CD, Ritz RH, Benson MS. Continuous in-line nebulizers complicate pressure support ventilation. Chest 96, 1360–1363 (1989).
   PubMed Web of Science ®Google Scholar
• Alvine GF, Rodgers P, Fitzsimmons KM, Ahrens RC. Disposable jet nebulizers: how reliable are they? Chest 101, 16–19 (1992).
   PubMedGoogle Scholar
• Summer W, Elston R, Tharpe S, Nelson S, Haponik EF. Aerosol bronchodilator delivery methods: relative impact on pulmonary function and cost of respiratory care. Arch. Intern. Med. 149, 618–623 (1989).
   PubMed Web of Science ®Google Scholar
• Bowton DL, Goldsmith WM, Haponik EF. Substitution of metered-dose inhalers for hand-held nebulizers: success and cost savings in a large, acute-care hospital. Chest 101, 305–308 (1992).
   PubMed Web of Science ®Google Scholar
• Klesper ME. Role of nebulized antibiotics for the treatment of respiratory infections. Curr. Opin. Infect. Dis. 17, 109–112 (2004).
   PubMedGoogle Scholar
• O’Riordan TG. Inhaled antimicrobial therapy: from cystic fibrosis to the flu. Respir. Care 45, 836–845 (2000).
   PubMedGoogle Scholar
• Dhand R, Tobin MJ. Inhaled bronchodilator therapy in mechanically ventilated patients. Am. J. Respir. Crit. Care Med. 156, 3–10 (1997).
   PubMed Web of Science ®Google Scholar
• Svartengren M, Anderson M, Philipson K, Camner P. Human lung deposition of particles suspended in air or in helium/oxygen mixture. Exp. Lung Res. 15, 575–585 (1989).
   PubMed Web of Science ®Google Scholar
• Goode ML, Fink JB, Dhand R, Tobin MJ. Improvements in aerosol delivery with helium–oxygen mixtures during mechanical ventilation. Am. J. Respir. Crit. Care Med. 163, 109–114 (2001).
   PubMed Web of Science ®Google Scholar
• O’Riordan TG, Greco MJ, Perry RJ, Smaldone GC. Nebulizer function during mechanical ventilation. Am. Rev. Respir. Dis. 145, 1117–1122 (1992).
   PubMed Web of Science ®Google Scholar
• O’Doherty MJ, Thomas SHL, Page CJ, Treacher DF, Nunan TO. Delivery of a nebulized aerosol to a lung model during mechanical ventilation: effect of ventilator settings and nebulizer type, position, and volume of fill. Am. Rev. Respir. Dis. 146, 383–388 (1992).
   PubMed Web of Science ®Google Scholar
• Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation: comparison of metered-dose inhaler and nebulizer efficiency. Am. J. Respir. Crit. Care Med. 152, 1391–1394 (1995).
   PubMed Web of Science ®Google Scholar
• Fink JB, Dhand R, Duarte AG, Jenne JW, Tobin MJ. Deposition of aerosol from metered-dose inhaler during mechanical ventilation: an in vitro model. Am. J. Respir. Crit. Care Med. 154, 382–387 (1996).
   PubMed Web of Science ®Google Scholar
• Feeley TW, Du Moulin GC, Hedey-Whyte J, Bushnell LS, Gilbert JP, Feingold DS. Aerosol polymyxin and pneumonia in seriously ill patients. N. Engl. J. Med. 293, 471–475 (1975).
   PubMed Web of Science ®Google Scholar
• Klick JM, Du Moulin GC, Hedley-Whyte J, Teres D, Bushnell LS, Feingold DS. Prevention of Gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. J. Clin. Invest. 555, 514–519 (1975).
   Google Scholar
• Klastersky J, Hensgens C, Noterman J, Mouawad E, Meunier-Carpentier F. Endotracheal antibiotics for the prevention of tracheobronchial infections in tracheotomized unconscious patients. A comparative study of gentamicin and aminosidin–polymyxin B combination. Chest 68, 302–306 (1975).
   PubMed Web of Science ®Google Scholar
• Klastersky J, Huysmans E, Weerts D, Hensgens C, Daneau D. Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: a double-blind study. Chest 65, 650–654 (1974).
   PubMed Web of Science ®Google Scholar
• Klastersky J, Cappel R, Noterman J, Snoeck J, Geuning C, Mouawad E. Endotracheal gentamicin for the prevention of bronchial infections in patients with tracheotomy. Int. J. Clin. Pharmacol. 7, 279–286 (1973).
   PubMedGoogle Scholar
• Klastersky J, Carpentier-Meunier F, Kahan-Coppens L et al. Endotracheally administered antibiotics for Gram-negative bronchopneumonia. Chest 75, 586–591 (1979).
   PubMed Web of Science ®Google Scholar
• Rathgeber J, Zielmann S, Panzer C et al. Prevention of pneumonia by endotracheal micronbulization of tobramycin. Anaesthesiol. Intensivemed. Notfallmed. Schmerzther. 28, 23–29 (1993).
   Google Scholar
• Rouby JJ, Poete P, de Lassale ME et al. Prevention of Gram-negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Intensive Care Med. 20, 187–192 (1994).
   PubMed Web of Science ®Google Scholar
• Wood C, Boucher BA, Croce MA, Hanes SD, Herring VL, Fabian TC. Aerosolized ceftazidime for prevention on ventilator-associated pneumonia and drug effects on the pro-inflammatory response in critically ill trauma patients. Pharmacotherapy 22, 972–982 (2002).
   PubMed Web of Science ®Google Scholar
• Wood CG, Boucher BA. Aerosolized antimicrobial therapy in acutely ill patients. Pharmacotherapy 20, 166–181 (2000).
   PubMed Web of Science ®Google Scholar
• Dodek P, Keenan S, Cook D. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann. Intern. Med. 141, 305–313 (2004).
   PubMed Web of Science ®Google Scholar
• Stoutenbeek CP, van Saene HKF, Miranda DR, Zandsra DF, Langrehr D. Nonsocomial Gram-negative pneumonia in critically ill patients. Intensive Care Med. 12, 419–423 (1986).
   PubMedGoogle Scholar
• LeConte P, Potel G, Clementi E et al. Administration of tobramycin aerosols in patients with nosocomial pneumonia: a preliminary study. Presse Med. 29, 76–78 (2000).
   PubMedGoogle Scholar
• Orriols R, Roig J, Ferrer J et al. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir. Med. 93, 476–480 (1999).
   PubMed Web of Science ®Google Scholar
• Ruijgrok EJ, Vulto AG, Van Etten EWM. Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats. J. Antimicrob. Chemother. 48, 89–95 (2001).
   PubMed Web of Science ®Google Scholar
• Sobieszczyk ME, Furuya EY, Hay CM et al. Combination therapy with polymyxin B for the treatment of multi-drug resistant Gram-negative respiratory tract infections. J. Antimicrob. Chemother. 54, 566–569 (2004).
   PubMed Web of Science ®Google Scholar
• Michalopoulos A, Kasiakou SK, Mastora Z, Rellow K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multi-drug resistant Gram-negative bacteria in patients without cystic fibrosis. Crit. Care. 9, R53–R59 (2005).
   PubMed Web of Science ®Google Scholar
• Brown RB, Kruse JA, Counts GW et al. Double-blind study of endotracheal tobramycin in the treatment of Gram-negative bacterial pneumonia. Antimicrob. Agents Chemother. 34, 269–272 (1990).
   PubMedGoogle Scholar
• Sherry E, Warnke PH. Successful use of an inhalational phytochemical to treat pulmonary tuberculosis: a case report. Phytomedicine 11, 95–97 (2004).
   PubMed Web of Science ®Google Scholar
• Erjavec Z, Woolthuis GM, de Vries-Hospers HG et al. Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients. Eur. J. Clin. Microbiol. Infect. Dis. 16, 364–368 (1997).
   PubMed Web of Science ®Google Scholar
• Hertenstein B, Kern WV, Schmeiser T et al. Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann. Hematol. 58, 21–26 (1994).
   Google Scholar
• Schwartz S, Behre G, Heinemann V et al. Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial. Blood 93, 3654–3661 (1999).
   PubMed Web of Science ®Google Scholar